178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

• Li Liu,
• Simon Turcotte,
• Shari Pilon-Thomas,
• Doris Wiener,
• Brian Czerniecki,
• Matthew Beatty,
• Larissa Pikor,
• Urminder Singh,
• Christian E Laing,
• Jacob Gibson,
• Anna Kluew,
• Mahdi Golkaram,
• Sven Bilke,
• Nathalie Brassard,
• Stewart E Abbot,
• Timothy J Langer,
• Grace DeSantis,
• Michael J Ciancanelli,
• Jeff H Tsai

Affiliations

Li Liu

1Illumina, San Diego, CA, USA

Simon Turcotte

4Université de Montréal, Montreal, QC, Canada

Shari Pilon-Thomas

6H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Doris Wiener

5Moffitt Cancer Center, Tampa, FL, USA

Brian Czerniecki

5Moffitt Cancer Center, Tampa, FL, USA

Matthew Beatty

5Moffitt Cancer Center, Tampa, FL, USA

Larissa Pikor

Turnstone Biologics, San Diego, CA, USA

Urminder Singh

1Illumina, San Diego, CA, USA

Christian E Laing

2Turnstone Biologics, Carlsbad, CA, USA

Jacob Gibson

1Illumina, San Diego, CA, USA

Anna Kluew

3Turnstone Biologics, San Diego, CA, USA

Mahdi Golkaram

1Illumina, San Diego, CA, USA

Sven Bilke

1Illumina, San Diego, CA, USA

Nathalie Brassard

4Université de Montréal, Montreal, QC, Canada

Stewart E Abbot

3Turnstone Biologics, San Diego, CA, USA

Timothy J Langer

3Turnstone Biologics, San Diego, CA, USA

Grace DeSantis

1Illumina, San Diego, CA, USA

Michael J Ciancanelli

3Turnstone Biologics, San Diego, CA, USA

Jeff H Tsai

1Illumina, San Diego, CA, USA